8.3.1 Hormone responsive prostate cancer
NICE NG131: Prostate cancer: diagnosis and management
All GnRH analogues are equally effective and specialists will continue to recommend treatment with a 'GnRH analogue' rather than a specific brand of product unless clinically indicated.
Specialists agree that GPs can change the product prescribed within this class of therapy to complete courses of therapy for existing patients as clinically appropriate and after informed discussions with the patient.
Formulary 1st choice
| Pack |
|---|
| 1 pre-filled disposable injection |
| Pack |
|---|
| 1 pre-filled disposable injection |
Also licensed for use in breast cancer
| Pack |
|---|
| 1 pre-filled disposable injection |
| Pack |
|---|
| 1 pre-filled disposable injection |
Degarelix is a GnRH antagonist
Starting dose to be administered in secondary care
| Pack |
|---|
| 2 vial |
| Pack |
|---|
| 1 vial |
- First Line Drugs
- Second Line Drugs
- Specialist Initiated Drugs
- Specialist Only Drugs
- Mixed Status